Hinge Health, INC Form 4 insider transactions

Executive Chairman Gabriel Mecklenburg sold 50,000 shares of Hinge Health Class A Common Stock via a Rule 10b5-1 trading plan.

CEO and Co-Founder Daniel Antonio Perez reported the sale of 150,000 shares of Class A Common Stock via a Rule 10b5-1 trading plan.

Hinge Health President James Pursley reported a transaction involving the sale of Class A Common Stock.

Hinge Health, Inc. Chief Financial Officer, James Budge, reported a transaction involving Class A Common Stock on May 1, 2026.

Hinge Health's Exec Chairman and Co-Founder, Gabriel Mecklenburg, sold 33,333 shares of Class A Common Stock for approximately $45.04 per share under a pre-arranged 10b5-1 trading plan.

Tyler Sloat, a Director at Hinge Health, Inc., acquired 68 shares of Class A Common Stock through the settlement of vested RSUs on April 5, 2026.

Hinge Health's Exec. Chairman & Co-Founder, Gabriel Mecklenburg, reported transactions involving Class A Common Stock, including acquisitions and dispositions under a Rule 10b5-1 trading plan.

Hinge Health President James Pursley disposed of 831 Class A Common Stock shares on April 1, 2026, to cover tax withholding obligations related to restricted stock unit vesting.

Hinge Health's Chief Financial Officer, James Budge, disposed of 4,614 Class A Common Stock shares on April 1, 2026, to cover tax liabilities from vested restricted stock units.

Hinge Health's CFO, James Budge, sold a total of 11,006 shares of Class A Common Stock on March 23, 2026, under a pre-arranged 10b5-1 trading plan.

Hinge Health President James Pursley sold 15,000 shares of Class A Common Stock for over $630,000 through a pre-arranged trading plan.

Hinge Health's President, James Pursley, reported a disposition of 5,127 Class A Common Stock shares for tax withholding related to RSU vesting.

Hinge Health CFO James Budge disposed of 7,699 Class A Common Stock shares to cover tax liabilities from RSU vesting.

Hinge Health President James Pursley sold 15,000 shares of Class A Common Stock for approximately $590,000 through a pre-arranged 10b5-1 trading plan.

Hinge Health's Chief Financial Officer, James Budge, has filed a Form 4 detailing planned sales of Class A Common Stock in February 2026 under a pre-arranged 10b5-1 trading plan.

Funds affiliated with Hinge Health director Elliott Robinson sold over 183,000 shares of Class A Common Stock in two separate transactions.

Hinge Health CEO Daniel Antonio Perez converted Class B shares to Class A and subsequently gifted Class A shares, impacting indirect beneficial ownership.

Hinge Health CEO Daniel Antonio Perez sold 166,665 shares of Class A Common Stock for approximately $40.26 per share under a pre-arranged trading plan.

Hinge Health President James Pursley disposed of 1,429 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.

Hinge Health's Chief Financial Officer, James Budge, disposed of 3,036 shares of Class A Common Stock to cover tax liabilities related to vested restricted stock units.

Hinge Health CEO Daniel Antonio Perez reported the sale of 166,665 Class A Common Stock shares on January 5, 2026, executed under a pre-arranged 10b5-1 trading plan.

Hinge Health President James Pursley disposed of 1,118 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.

Hinge Health's Chief Financial Officer, James Budge, reported the disposition of 3,243 Class A Common Stock shares to cover tax liabilities from restricted stock unit vesting.

Hinge Health, Inc. President James Pursley reported the sale of 15,000 Class A Common Stock shares at a weighted average price of $48.3967, executed under a Rule 10b5-1 trading plan.

Hinge Health's Chief Financial Officer, James Budge, sold 10,491 shares of Class A Common Stock for approximately $48.41 per share under a pre-arranged trading plan.

Hinge Health CEO Daniel Perez executed pre-planned sales of Class A common stock totaling approximately $8.09 million, following a conversion from Class B shares.

Hinge Health's Chief Financial Officer, James Budge, reported a pre-planned gift of 20,000 Class A Common Stock shares.

Hinge Health CEO Daniel Antonio Perez reported the conversion of Class B shares to Class A, followed by a gift of Class A common stock.

A director and 10% owner of Hinge Health, Elliott Robinson, reported an indirect sale of Class A Common Stock by Bessemer Venture Partners funds.

Insight Holdings Group and related entities reported the conversion and sale of over 1.6 million Hinge Health Class A Common Stock shares for $47.76 each.